Aging and Estrogenic Control of the Bioenergetic System in Brain
Aging and Estrogenic Control of the Bioenergetic System in Brain
批准号:
10405726
负责人:
ROBERTA EILEEN BRINTON
金额:
$53.73万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-03-15 至 2027-03-31
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseBioenergeticsBrainClinicalDataEstradiolEstrogen Receptor alphaEstrogensFaceFeedbackFemaleFeminizationGene ExpressionGene Expression ProfileGenerationsGenetic TranscriptionGenomicsGlucoseGoalsHormonesLeadMenopauseMental DepressionMetabolicMitochondriaMonitorMultiple SclerosisNeurodegenerative DisordersNeurologicNeuronsNuclearOutcomeOxidation-ReductionPathway interactionsPatternPerformancePostmenopausePrevalenceProcessProtein IsoformsPublic HealthRegulationRegulatory PathwayResearchRespirationRiskRoleSeriesSignal TransductionSystemSystems BiologyTestingTimeTranscriptional RegulationWomanWomen&aposs Healthage relatedagedaging brainaging populationcell growth regulationcell typeclinically significantdesigndisorder riskestrogenicfunctional outcomesglucose metabolismglucose transportinsightmenmind controlmitochondrial genomenervous system disorderprogramsreproductiveresponsetherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Our earlier mechanistic analyses of estrogen action in brain led to the discovery that estrogen is a master
regulator of the bioenergetic system in brain that promotes glucose transport, glucose metabolism,
mitochondrial respiration and ATP generation. Collectively, the data provided compelling evidence for estrogen
as a systems biology metabolic regulator in brain and illuminated compensatory mechanisms consistent with
an aging female brain that is starving. For estrogen to function as master regulator of the bioenergetic system
in the female brain, estrogen must be integrating nuclear and mitochondrial genomic responses. Further from a
systems level perspective, it would be necessary for estrogen to also regulate cytoplasmic signaling
mechanisms for real time feedback on the functional outcomes of nuclear and mitochondrial gene transcription.
The fundamental issues to be investigated are the mechanisms whereby estrogen integrates bioenergetic
responses across two genomic compartments while simultaneously monitoring energetic demand and
performance in real time. The proposed program of research is designed to test two hypotheses. First,
estrogenic control of the bioenergetic system in the female brain requires: 1) both nuclear and mitochondrial
genomes; 2) integration of gene expression across both genomic compartments and 3) activation of rapid
signaling cascades to provide real time feedback on bioenergetic performance. Second, we hypothesize that
loss of estrogen in the aging female brain leads to a systematic dis-integration of estrogenic control of nuclear
and mitochondrial genomes followed by decline in bioenergetic sensing mechanisms. Estrogenic control of the
bioenergetic system of the brain and the dismantling thereof has basic, translational and clinical significance.
From a discovery perspective the proposed program of research is unique in exploring the mechanisms
underlying estrogenic integration of nuclear and mitochondrial gene expression and the real time feedback
mechanisms that control the bioenergetic system of the brain. Further, the process by which this control
system is dismantled in the aging female brain is uncharted territory of high significance for understanding
bioenergetic aging in brain. Translationally, determining the mechanisms underlying the systematic dismantling
of estrogenic integration of bioenergetic compartments in brain has the potential to detect therapeutic targets to
sustain bioenergetic function in the aging female brain. Clinically, the aging transition of menopause, unique to
the female, is a process that dismantles both reproductive ability and potentially bioenergetic capacity in brain.
This is particularly relevant to age-related neurological conditions associated with deficits in glucose
hypometabolism such as Alzheimer's, depression and multiple sclerosis which have greater prevalence in
postmenopausal women. Research proposed herein aligns with NIA Strategic Research Goals A and C and
the “need to better distinguish patterns of brain aging” https://www.nia.nih.gov/about/living-long-well-21st-
century-strategic-directions-research-aging and to objectives of Office of Research on Women's Health.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Translational Research in Alzheimer's Disease and related Dementias (TRADD)
-
批准号:10709167
-
项目类别:
-
资助金额:$29.45万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel Intranasal Formulations of Allopregnanolone, a Regenerative Therapeutic for Alzheimer's Disease
-
批准号:10698555
-
项目类别:
-
资助金额:$50.58万
-
财政年份:2023
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10560591
-
项目类别:
-
资助金额:$154.45万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM Efficacy to Prevent Menopause Associated Decline in Brain Metabolism and Cognition: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial
-
批准号:10344556
-
项目类别:
-
资助金额:$212.12万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10547639
-
项目类别:
-
资助金额:$133.74万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
PhytoSERM for Menopausal Hot Flashes and Sustained Brain Health
-
批准号:10707107
-
项目类别:
-
资助金额:$119.93万
-
财政年份:2022
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10689308
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Research Education Component
-
批准号:10264194
-
项目类别:
-
资助金额:$19.07万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10491851
-
项目类别:
-
资助金额:$27.95万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Regulatory and Human Study Operations (RHSO) Core C
-
批准号:10270190
-
项目类别:
-
资助金额:$28.71万
-
财政年份:2021
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10199069
-
项目类别:
-
资助金额:$23.88万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:9991710
-
项目类别:
-
资助金额:$737.08万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Novel formulations of Allopregnanolone to treat Alzheimer's Disease
-
批准号:9906039
-
项目类别:
-
资助金额:$44.99万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10411886
-
项目类别:
-
资助金额:$755.24万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Allopregnanolone as Regenerative Therapeutic for Alzheimer's: Phase 2 Clinical Trial
-
批准号:10674824
-
项目类别:
-
资助金额:$728.0万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:9793963
-
项目类别:
-
资助金额:$25.48万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10437663
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Undergraduate Readying for Burgeoning Research for American Indian Neuroscientists
-
批准号:10645075
-
项目类别:
-
资助金额:$23.65万
-
财政年份:2019
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Sex Differences in the Molecular Determinants of Alzheimer's Disease Risk: Prodromal Endophenotype
-
批准号:9770740
-
项目类别:
-
资助金额:$114.13万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
Translational Research in AD and related Dementias (TRADD)
-
批准号:10475657
-
项目类别:
-
资助金额:$20.87万
-
财政年份:2018
-
负责人:ROBERTA EILEEN BRINTON
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: